Asian Insight Provider - Actionable ideas, CrossASEAN Research

Henry Soediarko

Asian Insight Provider - Actionable ideas

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

Equity Bottom-Up

<p>Having increased its global market share from fifth to second in 2018 thanks to the technological advantages, the company's share price has disappointed its shareholders and underperformed its customers' in China due to its heavy reliance on US customers such as Ford and GM.</p><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/149/291/original/image_44632301051596175067736.png?1596175067" class="editor-image img-responsive" data-smartkarma-image-id="149291"></figure><div class="content-remarks"><p>source: Capital IQ</p></div><div>With the new initiative to focus more on China and Emerging Markets, the company creates an opportunity to diversify its revenue geographically and participate in the rebound in the Chinese auto sector. </div><div></div><div>The company is severely undervalued compared to the peers by 68% in PER and 38% in EV/EBITDA despite higher profitability (560% higher ROE) and leaner capital structure (50% better in D/E), showing <span>potential for re-rating</span>. </div><div></div><div>
<p>If the company's AES is to be implemented this year and adopted by various customers in China to start with, then the revenue that the company receives will bolster its current net income (USD 232.4 million) by around 38% to 570% in the next few years depending on the pace of the adoption and market share. Buy <a href="https://www.smartkarma.com/entities/nexteer-automotive-group-ltd" target="_blank" data-smartkarma-citation="entities:15483:1" rel="noopener">Nexteer Automotive (1316 HK)</a> .</p>
<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/149/289/original/image_65787491341596174865541.png?1596174865" class="editor-image img-responsive" data-smartkarma-image-id="149289"></figure><div class="content-remarks"><p>source: Capital IQ</p></div>
</div>

Having increased its global market share from fifth to second in 2018 thanks to the technological advantages, the company's share price has disappointed its shareholders and underperformed its customers' in China due to its heavy reliance on US customers such as Ford and GM.source: Capital IQWith the new initiative to focus more on China and Emerging Markets, the company creates an opportunity to diversify its revenue geographically and participate in the rebound in the Chinese auto sector. The company is severely undervalued compared to the peers by 68% in PER and 38% in EV/EBITDA despite higher profitability (560% higher ROE) and leaner capital structure (50% better in D/E), showing potential for re-rating. 
If the company's AES is to be implemented this year and adopted by various customers in China to start with, then the revenue that the company receives will bolster its current net income (USD 232.4 million) by around 38% to 570% in the next few years depending on the pace of the adoption and market share. Buy Nexteer Automotive (1316 HK) .
source: Capital IQ


Alpha-Centric ESG Research

Kyle Rudden

<p>"Social" has been a third-wheel ESG pillar for a long time. Not that it matters any less, and there is plenty of evidence that strong Social-pillar ESG performance can do a lot of  good for a stock price. Rather, it's that the Social pillar stuff is more ethereal, harder to wrap one's head around. And, let's face it, the Social ESG pillar is a little more rosewater than crude oil.</p><p>It is amazing how a global pandemic changes things. Whether it is ESG's social or Corporate Social Responsibility's (CSR) "social," socially-responsibility – as well as social irresponsibility or inaction – by corporations are front-and-center. In prior reports I assessed corporate coronavirus responses from an ESG perspective. In doing so, I something became increasingly (and painfully) obvious:</p><p>Company responses are <em>very</em> diverse (as they should be), making comparative analysis difficult.</p><p>For society, comparisons aren't necessarily relevant. A patient receiving better medical care due to a generous contribution from Company A probably doesn't care that Company B – same sector but the other side of the world – gave a larger contribution to its local hospital. For investors, however, comparisons kind of matter. After all, what's the value of a stand-alone P/E multiple?</p><p>Rather than go insane trying to standardise and normalise everything – e.g., the economic value of donated masks or cost of retrofitting manufacturing lines to produce ventilators – I decided to look at coronavirus-related corporate philanthropy as a comparative metric. It is universal, quantifiable, and decidedly much easier to measure and value than, say, vats of hand sanitiser.</p><p>This takes a data-driven look at coronavirus-related corporate social responsibility and specifically  philanthropy by listed companies in Asia Pacific countries. APAC first because Asian companies are doing a lot of giving, and nearly all of that inspirational cross-border humanitarian aid – including to the U.S., despite a certain orange-haired xenophobe in a white house.</p>

"Social" has been a third-wheel ESG pillar for a long time. Not that it matters any less, and there is plenty of evidence that strong Social-pillar ESG performance can do a lot of  good for a stock price. Rather, it's that the Social pillar stuff is more ethereal, harder to wrap one's head around. And, let's face it, the Social ESG pillar is a little more rosewater than crude oil.It is amazing how a global pandemic changes things. Whether it is ESG's social or Corporate Social Responsibility's (CSR) "social," socially-responsibility – as well as social irresponsibility or inaction – by corporations are front-and-center. In prior reports I assessed corporate coronavirus responses from an ESG perspective. In doing so, I something became increasingly (and painfully) obvious:Company responses are very diverse (as they should be), making comparative analysis difficult.For society, comparisons aren't necessarily relevant. A patient receiving better medical care due to a generous contribution from Company A probably doesn't care that Company B – same sector but the other side of the world – gave a larger contribution to its local hospital. For investors, however, comparisons kind of matter. After all, what's the value of a stand-alone P/E multiple?Rather than go insane trying to standardise and normalise everything – e.g., the economic value of donated masks or cost of retrofitting manufacturing lines to produce ventilators – I decided to look at coronavirus-related corporate philanthropy as a comparative metric. It is universal, quantifiable, and decidedly much easier to measure and value than, say, vats of hand sanitiser.This takes a data-driven look at coronavirus-related corporate social responsibility and specifically  philanthropy by listed companies in Asia Pacific countries. APAC first because Asian companies are doing a lot of giving, and nearly all of that inspirational cross-border humanitarian aid – including to the U.S., despite a certain orange-haired xenophobe in a white house.

COVID-19 and ESG: Tencent, Alibaba Lead in Coronavirus Aid for Asia Pacific Region

Equity Analyst, LightStream Research

Aqila Ali

Equity Analyst

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

<p><a href="https://www.smartkarma.com/entities/denso-corp" target="_blank" data-smartkarma-citation="entities:18703:1" rel="noopener">Denso Corp (6902 JP)</a> released FY03/20 results last Thursday, which were weak but weren’t particularly disappointing. Revenue and OP both declined YoY during the FY, with 4Q recording a loss according to the company’s revised guidance. The numbers were better than expected on the revenue side, beating consensus by +0.6% and its revised guidance by +0.1%. OP results were in line with the revised guidance and revised consensus estimate.</p><p>While the revenue decline appears reasonable, we have our doubts with regard to the reason for the -80% YoY decline in OP. The company cites provisions for quality costs as the reason for this situation, though we wonder what exactly these costs are for. It could be that Denso has accounted for the COVID impact well ahead of time.</p><p>Our analysis shows that the recent 4Q is similar to 4Q FY03/09, during the GFC. We wonder if the company is accounting for a significant portion of its upcoming expenses in a year that is essentially a write-off (FY03/20), to possibly surprise with better results and signs of recovery in the upcoming quarters, which was the case post-GFC. The company not giving guidance for FY03/21E increases the potential for a positive surprise further.  </p><p>Consensus and our estimates are for a weak 1H FY03/21E while expecting a recovery through FY03/21.</p><p>We go through the details below.</p>

Denso Corp (6902 JP) released FY03/20 results last Thursday, which were weak but weren’t particularly disappointing. Revenue and OP both declined YoY during the FY, with 4Q recording a loss according to the company’s revised guidance. The numbers were better than expected on the revenue side, beating consensus by +0.6% and its revised guidance by +0.1%. OP results were in line with the revised guidance and revised consensus estimate.While the revenue decline appears reasonable, we have our doubts with regard to the reason for the -80% YoY decline in OP. The company cites provisions for quality costs as the reason for this situation, though we wonder what exactly these costs are for. It could be that Denso has accounted for the COVID impact well ahead of time.Our analysis shows that the recent 4Q is similar to 4Q FY03/09, during the GFC. We wonder if the company is accounting for a significant portion of its upcoming expenses in a year that is essentially a write-off (FY03/20), to possibly surprise with better results and signs of recovery in the upcoming quarters, which was the case post-GFC. The company not giving guidance for FY03/21E increases the potential for a positive surprise further.  Consensus and our estimates are for a weak 1H FY03/21E while expecting a recovery through FY03/21.We go through the details below.

Denso: Weak 4Q FY03/20 Resembles GFC Times- Is Recovery Around the Corner?

'Quantamental' Japan Specialist, LightStream Research

Campbell Gunn

'Quantamental' Japan Specialist

Thematic (Sector/Industry)

<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/129/661/original/2020-04-26_07-20-46.png?1587853286" class="editor-image img-responsive" data-smartkarma-image-id="129661"></figure><div class="content-caption">Source • Japan Analytics</div><p><strong>THE WEDGE</strong> - Both Japanese equities and the $/¥ exchange rate have traded in a narrow range over the last two weeks. Undeterred, the Bank of Japan intervened through ETF purchases three times last week. In total, since the low of March 16th, the central bank has bought ETFs equivalent to 3.5% of market value, and have supported a 15% 29-day rally. As the markets consolidate in anticipation of the impending 'rendezvous with reality' in the form of quarterly earnings, the resolution of the 'wedge' formations above will be to the downside.</p><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/129/662/original/2020-04-26_07-39-05.png?1587854366" class="editor-image img-responsive" data-smartkarma-image-id="129662"></figure><div class="content-caption">Source • Japan Analytics</div><p><strong>CANARIES</strong> - As we noted in Friday's <a href="https://www.smartkarma.com/insights/japan-revisions-results-23rd-april-getting-worse-rapidly-obics-tgas-canon-omron" target="_blank" data-smartkarma-citation="insights:38697" rel="noopener">Results Review</a>, interim forecasts are a useful 'canary' and, with some help from <a href="https://www.smartkarma.com/entities/fanuc-corp" target="_blank" data-smartkarma-citation="entities:752:1" rel="noopener">Fanuc (6954 JP)</a>, our composite Score is heading lower rapidly. A growing number of companies lacking Fanuc's candour are refusing to make initial full-year or interim forecasts this year leaving the market, and the sell-side, to 'fly blind'. The lack of foresight is resulting in a degree of misplaced optimism, as amply demonstrated by Friday's 7.5% gain in <a href="https://www.smartkarma.com/entities/omron-corp" target="_blank" data-smartkarma-citation="entities:15904:1" rel="noopener">Omron (6645 JP)</a> for 'beating' a six-month-old forecast for a mostly pre-COVID-19 year.     </p><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/129/665/original/File%202020-04-26%205%2006%2033.jpeg?1587856452" class="editor-image img-responsive" data-smartkarma-image-id="129665"></figure><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/129/666/original/File%202020-04-26%205%2007%2018.jpeg?1587856466" class="editor-image img-responsive" data-smartkarma-image-id="129666"></figure><p><strong>PERSISTENCE</strong> - Japan is still 'behind' the world and ahead of the rest of Asia in COVID-19 metrics - Marco Piani's excellent global timeline chart is attached as an Appendix in the DETAIL below. The number of confirmed new cases is persistent at around 300, of which, alarmingly, an increasing number are outside Tokyo, while the rolling 3-day number of deaths is moving more towards Europe than the rest of Asia. The northern island of Hokkaido which saw some of the earliest case clusters in Japan is experiencing a second wave of infections.  Nishimura, the Cabinet minister in charge of the response to COVID-19, is now in quarantine at home after one of his aides tested positive. Sunday has brought some welcome good news - the nationwide daily case count has declined to 140. <strong>Nevertheless, with just ten days until the proposed end of the states of emergency, at least one extension is likely, possibly until the end of May. Such a declaration is not yet discounted in the equity market.</strong></p><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/129/667/original/IMG_1515.jpg?1587857128" class="editor-image img-responsive" data-smartkarma-image-id="129667"></figure><div class="content-caption">Source • NHK</div><p><strong>PREVALENCE</strong> - Although a lack of widespread testing biases this data, the detected rates of infection by age cohort (descending in the chart above) and sex (male blue/female red) reveal the consequences of Japan's version of social distancing. The highest rates of infection are amongst those that have to commute or come into contact with others, men between the ages of 20 and 50 and childless women in their twenties, many of whom work in hospitals or check-out counters. 10% of all COVID-19 cases in Japan are medical staff or patients who were infected nosocomially.  Testing is still a major bottleneck due to excessive fax-centric bureaucracy and reliance on only non-private institutions. Only 6,000 tests are being carried out every day, two-thirds of total capacity, and the results take one week to obtain. </p><p><strong>PLEASE DIE AT HOME</strong> - A number of those infected with COVID-19 who have been told to 'stay home' as the hospitals are full are now dying in situ or on the street. Some local governments are being forced to change tack. All newly-confirmed patients that cannot be accommodated in hospitals are to be moved to hotels with medical staff in attendance. However, there is now a severe shortage of such personnel. Hospitals in Tokyo are still turning away suspected COVID-19 patients. Aichi prefecture has resorted to offering 'subsidies' of up to ¥4 million to hospitals for accepting new patients.</p><p><strong>ANTI-SOCIAL BEHAVIOUR</strong> - Japan is not immune to anti-social behaviour at the worst of times. Cars with license plates from other prefectures have been vandalised when parked or tailgated or verbally-abused on the road. Child care facilities are turning away children of hospital staff for fear they may already be asymptomatic carriers, prompting many medical workers to quit their jobs. Some companies are requiring employees who are working from home to be monitored by video during working hours to ensure they are at their desks and not helping out with the housework.</p><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/129/670/original/title_1.jpg?1587859428" class="editor-image img-responsive" data-smartkarma-image-id="129670"></figure><div class="content-caption">Source • Sharp</div><p><strong>ABE-'NO-MASKS'</strong><strong>AND THE SHARP LOTTERY</strong> - The government has had to recall the small washable cloth masks that PM Abe planned to distribute two of per household due to mould, stains and insects being found in up to one-third of early batches. The roll-out of these much-criticised 'Abe masks' will be further delayed. Meanwhile, demand for <a href="https://www.smartkarma.com/entities/sharp-corp" target="_blank" data-smartkarma-citation="entities:391:1" rel="noopener">Sharp (6753 JP)</a>'s newly-manufactured higher quality single-use masks so overwhelmed the company's website, that Sharp has decided to hold a lottery as a way of rationing demand.</p><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/129/725/original/2020-04-26_15-42-04.png?1587883347" class="editor-image img-responsive" data-smartkarma-image-id="129725"></figure><div class="content-caption">Source ♦ Japan Analytics</div><p>In the<strong> DETAIL</strong> below, we shall review the results, revisions and initial forecast announcements made on Friday by larger-cap companies.  The positive/neutral/negative balance for Friday's 28 results announcements was 13:1:14, and the net change in Results Score was -1. For the 47 revisions/forecasts, the split was 21:2:24 but the net change in Revision Score totalled -170. Of the eighteen companies declaring full-year results, only half made interim or annual forecasts for the current year. As we shall see below the 'worst' forecasts were from <a href="https://www.smartkarma.com/entities/fanuc-corp" target="_blank" data-smartkarma-citation="entities:752:1" rel="noopener">Fanuc (6954 JP)</a>, <a href="https://www.smartkarma.com/entities/amano-corp" target="_blank" data-smartkarma-citation="entities:8135:1" rel="noopener">Amano (6436 JP)</a>, <a href="https://www.smartkarma.com/entities/ana-holdings-inc" target="_blank" data-smartkarma-citation="entities:5308:1" rel="noopener">ANA (9202 JP)</a>, and <a href="https://www.smartkarma.com/entities/denso-corp" target="_blank" data-smartkarma-citation="entities:18703:1" rel="noopener">Denso (6902 JP)</a> (see chart above). Large=caps with improved Revisions Scores were <a href="https://www.smartkarma.com/entities/mochida-pharmaceutical-co" target="_blank" data-smartkarma-citation="entities:3655:1" rel="noopener">Mochida Pharmaceutical (4534 JP)</a>, <a href="https://www.smartkarma.com/entities/okinawa-cellular-telephone" target="_blank" data-smartkarma-citation="entities:6517:1" rel="noopener">Okinawa Cellular Telephone (9436 JP)</a> and <a href="https://www.smartkarma.com/entities/acom-co-ltd" target="_blank" data-smartkarma-citation="entities:8897:1" rel="noopener">Acom (8572 JP)</a>. <a href="https://www.smartkarma.com/entities/shionogi-co-ltd" target="_blank" data-smartkarma-citation="entities:19535:1" rel="noopener">Shionogi (4507 JP)</a> and two other companies raised dividends; none cut their payouts.</p>

Source • Japan AnalyticsTHE WEDGE - Both Japanese equities and the $/¥ exchange rate have traded in a narrow range over the last two weeks. Undeterred, the Bank of Japan intervened through ETF purchases three times last week. In total, since the low of March 16th, the central bank has bought ETFs equivalent to 3.5% of market value, and have supported a 15% 29-day rally. As the markets consolidate in anticipation of the impending 'rendezvous with reality' in the form of quarterly earnings, the resolution of the 'wedge' formations above will be to the downside.Source • Japan AnalyticsCANARIES - As we noted in Friday's Results Review, interim forecasts are a useful 'canary' and, with some help from Fanuc (6954 JP), our composite Score is heading lower rapidly. A growing number of companies lacking Fanuc's candour are refusing to make initial full-year or interim forecasts this year leaving the market, and the sell-side, to 'fly blind'. The lack of foresight is resulting in a degree of misplaced optimism, as amply demonstrated by Friday's 7.5% gain in Omron (6645 JP) for 'beating' a six-month-old forecast for a mostly pre-COVID-19 year.     PERSISTENCE - Japan is still 'behind' the world and ahead of the rest of Asia in COVID-19 metrics - Marco Piani's excellent global timeline chart is attached as an Appendix in the DETAIL below. The number of confirmed new cases is persistent at around 300, of which, alarmingly, an increasing number are outside Tokyo, while the rolling 3-day number of deaths is moving more towards Europe than the rest of Asia. The northern island of Hokkaido which saw some of the earliest case clusters in Japan is experiencing a second wave of infections.  Nishimura, the Cabinet minister in charge of the response to COVID-19, is now in quarantine at home after one of his aides tested positive. Sunday has brought some welcome good news - the nationwide daily case count has declined to 140. Nevertheless, with just ten days until the proposed end of the states of emergency, at least one extension is likely, possibly until the end of May. Such a declaration is not yet discounted in the equity market.Source • NHKPREVALENCE - Although a lack of widespread testing biases this data, the detected rates of infection by age cohort (descending in the chart above) and sex (male blue/female red) reveal the consequences of Japan's version of social distancing. The highest rates of infection are amongst those that have to commute or come into contact with others, men between the ages of 20 and 50 and childless women in their twenties, many of whom work in hospitals or check-out counters. 10% of all COVID-19 cases in Japan are medical staff or patients who were infected nosocomially.  Testing is still a major bottleneck due to excessive fax-centric bureaucracy and reliance on only non-private institutions. Only 6,000 tests are being carried out every day, two-thirds of total capacity, and the results take one week to obtain. PLEASE DIE AT HOME - A number of those infected with COVID-19 who have been told to 'stay home' as the hospitals are full are now dying in situ or on the street. Some local governments are being forced to change tack. All newly-confirmed patients that cannot be accommodated in hospitals are to be moved to hotels with medical staff in attendance. However, there is now a severe shortage of such personnel. Hospitals in Tokyo are still turning away suspected COVID-19 patients. Aichi prefecture has resorted to offering 'subsidies' of up to ¥4 million to hospitals for accepting new patients.ANTI-SOCIAL BEHAVIOUR - Japan is not immune to anti-social behaviour at the worst of times. Cars with license plates from other prefectures have been vandalised when parked or tailgated or verbally-abused on the road. Child care facilities are turning away children of hospital staff for fear they may already be asymptomatic carriers, prompting many medical workers to quit their jobs. Some companies are requiring employees who are working from home to be monitored by video during working hours to ensure they are at their desks and not helping out with the housework.Source • SharpABE-'NO-MASKS'AND THE SHARP LOTTERY - The government has had to recall the small washable cloth masks that PM Abe planned to distribute two of per household due to mould, stains and insects being found in up to one-third of early batches. The roll-out of these much-criticised 'Abe masks' will be further delayed. Meanwhile, demand for Sharp (6753 JP)'s newly-manufactured higher quality single-use masks so overwhelmed the company's website, that Sharp has decided to hold a lottery as a way of rationing demand.Source ♦ Japan AnalyticsIn the DETAIL below, we shall review the results, revisions and initial forecast announcements made on Friday by larger-cap companies.  The positive/neutral/negative balance for Friday's 28 results announcements was 13:1:14, and the net change in Results Score was -1. For the 47 revisions/forecasts, the split was 21:2:24 but the net change in Revision Score totalled -170. Of the eighteen companies declaring full-year results, only half made interim or annual forecasts for the current year. As we shall see below the 'worst' forecasts were from Fanuc (6954 JP), Amano (6436 JP), ANA (9202 JP), and Denso (6902 JP) (see chart above). Large=caps with improved Revisions Scores were Mochida Pharmaceutical (4534 JP), Okinawa Cellular Telephone (9436 JP) and Acom (8572 JP). Shionogi (4507 JP) and two other companies raised dividends; none cut their payouts.

🇯🇵 JAPAN MARKET (& COVID-19) UPDATE 26th April - Thin End of the Wedge

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Quantitative Analysis

<p>The GPIF is the world's largest pension fund at what was $1.6 trillion-plus at the end of December 2019. </p><p>The management of the GPIF has made remarkable strides in recent years, moving towards market targets for returns of all assets (no more FILP bonds), creating a win-win profitability structure for active managers on multi-year mandates (up to five to seven years it seems), and demanding accountability on stewardship policies and efforts. </p><p>In March 2010, the GPIF lowered its domestic bond portfolio bogey from 67% to 60% (which was good because it was already there),  and raised its domestic equity, foreign bond, and foreign equity allocation mix midpoints to 12%/11%/12% from 11%/8%/9%. Short Term Assets were set at 5%. </p><p>In June 2013, they realized they needed to be more aggressive, and so the GPIF spent more than a year studying the problem, having experts in, looking at allocation mixes and trying to be more professional about assessing their liability profile and curve, and decided in October 2014 to implement a much different mix, moving domestic bonds to 35% ±10%, domestic equities to 25% ±9%, foreign bonds to 15% ±4%, and foreign equities to 25% ±8%. There was no bogey for Short Term Assets, but that was assumed to be wrapped up in the domestic bonds portion as a concept.</p><p>That meant buying equities, and they did.</p><p>They had already been buying and by the time they announced the new policy in October 2014 officially, they had already gone through the old limits on domestic equities and were at 18.2% (the old upper limit was 18.0%). It took them until March 2015 to get to 22%, and by June they were at 23.4%. </p><p>Basically, they then let it ride, with some small changes here and there. The big changes were constant reductions in the domestic bond allocation. However in FY15 (year to March 2016) there was an episode of equity buying. That is probably something those interested in flows should study now. </p><p>The GPIF is currently said to be in the process of conducting an Investment Policy Review. The lead-up to this has seen a number of changes which hint at what could come.</p><ol>
<li>
<strong>The GPIF has become very ESG-focussed.</strong> Some of that is the G portion where they talk about being long-term investors, and they have made it mandatory for their investment managers to have a stewardship policy and report on how they execute that policy. They are also looking very much at the longer-term, and CIO Mizuno has blasted short-sellers and any number of other market participants for being short-term (I had issues with a bunch of the comments reported in the FT so got a <a href="https://ftalphaville.ft.com/2020/01/14/1579000419000/The-GPIF-and-the-complexity-of-stewardship/" target="_blank" rel="noopener">letter to Alphaville</a> published - Thanks Jamie!).</li>
<li><strong>The GPIF has started looking at real estate.</strong></li>
<li>
<strong>The GPIF has decided that foreign credit which is yen-hedged can be put into the domestic bonds allocation bucket.</strong> This means a higher allocation to foreign issuer risk than the old limit.</li>
<li>
<strong>The GPIF has stopped lending stocks.</strong> This reduces fee income to passive portfolios (foreign equity, as domestic equity lending has never been done, or at least not in many, many years) but it means more pressure on company management.</li>
<li>
<strong>The GPIF has changed the way contracts work for active managers.</strong> The base concept, according to interviews and articles, is that the active manager gets the same very low management fee on AUM as a passive manager does, but the active manager shares in the upside over the life of the contract, which will be "one market cycle" (i.e. five years, or seven years, or whatever they settle on with the GPIF). This should, ceteris paribus, lead to further outperformance. </li>
</ol><p>All of these things would, in my mind, point to a higher domestic equity allocation, a higher foreign bond allocation, and a shift to more active management and less passive management in domestic equities (last year the split was 90% passive 10% active). </p><p>But there are shorter-term factors investors should be looking at. </p><p>More discussion below.</p>

The GPIF is the world's largest pension fund at what was $1.6 trillion-plus at the end of December 2019. The management of the GPIF has made remarkable strides in recent years, moving towards market targets for returns of all assets (no more FILP bonds), creating a win-win profitability structure for active managers on multi-year mandates (up to five to seven years it seems), and demanding accountability on stewardship policies and efforts. In March 2010, the GPIF lowered its domestic bond portfolio bogey from 67% to 60% (which was good because it was already there),  and raised its domestic equity, foreign bond, and foreign equity allocation mix midpoints to 12%/11%/12% from 11%/8%/9%. Short Term Assets were set at 5%. In June 2013, they realized they needed to be more aggressive, and so the GPIF spent more than a year studying the problem, having experts in, looking at allocation mixes and trying to be more professional about assessing their liability profile and curve, and decided in October 2014 to implement a much different mix, moving domestic bonds to 35% ±10%, domestic equities to 25% ±9%, foreign bonds to 15% ±4%, and foreign equities to 25% ±8%. There was no bogey for Short Term Assets, but that was assumed to be wrapped up in the domestic bonds portion as a concept.That meant buying equities, and they did.They had already been buying and by the time they announced the new policy in October 2014 officially, they had already gone through the old limits on domestic equities and were at 18.2% (the old upper limit was 18.0%). It took them until March 2015 to get to 22%, and by June they were at 23.4%. Basically, they then let it ride, with some small changes here and there. The big changes were constant reductions in the domestic bond allocation. However in FY15 (year to March 2016) there was an episode of equity buying. That is probably something those interested in flows should study now. The GPIF is currently said to be in the process of conducting an Investment Policy Review. The lead-up to this has seen a number of changes which hint at what could come.

The GPIF has become very ESG-focussed. Some of that is the G portion where they talk about being long-term investors, and they have made it mandatory for their investment managers to have a stewardship policy and report on how they execute that policy. They are also looking very much at the longer-term, and CIO Mizuno has blasted short-sellers and any number of other market participants for being short-term (I had issues with a bunch of the comments reported in the FT so got a letter to Alphaville published - Thanks Jamie!).
The GPIF has started looking at real estate.

The GPIF has decided that foreign credit which is yen-hedged can be put into the domestic bonds allocation bucket. This means a higher allocation to foreign issuer risk than the old limit.

The GPIF has stopped lending stocks. This reduces fee income to passive portfolios (foreign equity, as domestic equity lending has never been done, or at least not in many, many years) but it means more pressure on company management.

The GPIF has changed the way contracts work for active managers. The base concept, according to interviews and articles, is that the active manager gets the same very low management fee on AUM as a passive manager does, but the active manager shares in the upside over the life of the contract, which will be "one market cycle" (i.e. five years, or seven years, or whatever they settle on with the GPIF). This should, ceteris paribus, lead to further outperformance. 
All of these things would, in my mind, point to a higher domestic equity allocation, a higher foreign bond allocation, and a shift to more active management and less passive management in domestic equities (last year the split was 90% passive 10% active). But there are shorter-term factors investors should be looking at. More discussion below.

Japan

DENSO CORPORATION manufactures electronic parts for automobiles.  The Company's products include automobile air conditioners, air bags, ignition systems, generators, power steering systems, and spark plugs with iridium electrode. The Company also produces communication equipment for mobile navigation system.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Denso Corp (6902 JP)

Nexteer (1316): AES to the Rescue

Having increased its global market share from fifth to second in 2018 thanks to the technological advantages, the company's share price has...

Henry Soediarko

COVID-19 and ESG: Tencent, Alibaba Lead in Coronavirus Aid for Asia Pacific Region

"Social" has been a third-wheel ESG pillar for a long time. Not that it matters any less, and there is plenty of evidence that strong Social-pillar...

Kyle Rudden

Denso: Weak 4Q FY03/20 Resembles GFC Times- Is Recovery Around the Corner?

Denso Corp (6902 JP) released FY03/20 results last Thursday, which were weak but weren’t particularly disappointing. Revenue and OP both declined...

Aqila Ali

🇯🇵 JAPAN MARKET (& COVID-19) UPDATE 26th April - Thin End of the Wedge

THE WEDGE - Both Japanese equities and the $/¥ exchange rate have traded in a narrow range over the last two weeks. Undeterred, the Bank of Japan...

Campbell Gunn

JAPAN DELTA IV - Is The GPIF In Buying?

The GPIF is the world's largest pension fund at what was $1.6 trillion-plus at the end of December 2019. The management of the GPIF has made...

Travis Lundy

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)